WHO ATTENDS

 

 

BIG DATA, RISK AND PV
 

WHO ATTENDS:

Pharma and biotechs:

  • Heads of PV
  • Heads of Safety and Clinical Trials
  • Heads of Data Management
  • Heads of Risk Management
  • Heads of Regulation

 

TOPICS:

  • How to capture data – quantity and quality
  • How to perfect post marketing authorization
  • How to assess risk in the lifecycle
  • How to uncover opportunities in pharmacoepidemiology
  • How to compare outsourcing opportunities and vendors: pricing, track record, size

NEXT GEN TECH
 

WHO ATTENDS:

  • Technology innovators
  • Pharma and biotechs looking at AI
  • Heads of Safety Surveillance

 

TOPICS:

  • How to optimize safety signal detection and management
  • How to achieve global harmonization of PV
  • How to adopt AI into PV strategy
  • How to use tech to transform clinical trials
  • How to compare and understand new technologies

PATIENT CENTRICITY AND MEDICAL DEVICES

WHO ATTENDS:

  • Medical Directors
  • Medical Device Experts

 

TOPICS:

  • How to redefine clinical trials around the patient
  • How to automate PV and make trials easier for patients
  • How to explore innovation in safety monitoring devices
  • How to implement microphysiological systems
  • How to develop combinational products and ensure security for devices

TOXICOLOGY
 

WHO ATTENDS:

  • Pharma and biotech toxicology professionals

 

TOPICS:

  • How to reduce the chances of late stage ADRs
  • How to model complex protein structures
  • How to enhance genomic screening techniques
  • How to improve compliance in toxicology
  • How to compare ADME/DMPK service providers

 

 

DOWNLOAD PROSPECTUS

 

Get Involved At World Drug Safety Congress Americas

 

To Sponsor Or Exhibit


Joseph Sica
joseph.sica@terrapinn.com
t/ +1 646 619 1839

 

 

 

To Speak


Michaela Dietrick
michaela.dietrick@terrapinn.com
t/ +1 646 619 1841

 

 

 

To Register


Peter Kloak
peter.kloak@terrapinn.com
t/ +1 646 619 1779